Freiser Eceomo Cruz Mosquera, Elizabeth Camacho Benítez, Mariatta Catalina Ceballos Benavides, Julián Esteban Castillo Muñoz, Carlos Andrés Castañeda, Yamil Liscano
{"title":"乳酸林格氏液复苏vs生理盐水治疗急性胰腺炎:临床试验的系统回顾和荟萃分析","authors":"Freiser Eceomo Cruz Mosquera, Elizabeth Camacho Benítez, Mariatta Catalina Ceballos Benavides, Julián Esteban Castillo Muñoz, Carlos Andrés Castañeda, Yamil Liscano","doi":"10.3390/diseases13090300","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Initial fluid therapy in acute pancreatitis is critical for modulating the systemic inflammatory response. The choice between Lactated Ringer and normal saline remains debated, given their potentially divergent impacts on disease progression and clinically relevant outcomes. The objective of this meta-analysis is to determine the effectiveness of one solution versus the other in patients with AP.</p><p><strong>Methods: </strong>A systematic review of randomized clinical trials published between 2000 and 2024 was conducted through an exhaustive search in databases such as PubMed, ScienceDirect, LILACS, SCOPUS, Web of Science, Springer, Scielo, and Cochrane. The review protocol adhered to the recommendations established by PRISMA. The methodological quality of the selected studies was assessed using the Jadad scale, while statistical analyses were performed with RevMan 5.4<sup>®</sup> and Jamovi 2.3.28<sup>®</sup> software.</p><p><strong>Results: </strong>Five trials with 299 patients showed that, in patients with AP, Lactated Ringer significantly reduced ICU admission (RR: 0.39; 95% CI: 0.18-0.85; <i>p</i> = 0.02) and the progression of pancreatitis (RR: 0.63; 95% CI: 0.40-0.98; <i>p</i> = 0.04). There was no significant difference in mortality or hospital stay (SMD: -0.89; 95% CI: -2.26 to 0.48; <i>p</i> = 0.23). No clear effects were observed on SIRS at 24, 48, and 72 h. CRP at 48 h was significantly lower with lactate (SMD: -3.91; 95% CI: -4.66 to -3.17; <i>p</i> < 0.00001), but not at 72 h.</p><p><strong>Conclusions: </strong>The administration of Lactated Ringer in acute pancreatitis shows clinical and anti-inflammatory benefits, but the evidence is mostly of low quality.</p>","PeriodicalId":72832,"journal":{"name":"Diseases (Basel, Switzerland)","volume":"13 9","pages":""},"PeriodicalIF":3.0000,"publicationDate":"2025-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12468465/pdf/","citationCount":"0","resultStr":"{\"title\":\"Fluid Resuscitation with Lactated Ringer vs. Normal Saline in Acute Pancreatitis: A Systematic Review and Meta-Analysis of Clinical Trials.\",\"authors\":\"Freiser Eceomo Cruz Mosquera, Elizabeth Camacho Benítez, Mariatta Catalina Ceballos Benavides, Julián Esteban Castillo Muñoz, Carlos Andrés Castañeda, Yamil Liscano\",\"doi\":\"10.3390/diseases13090300\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Initial fluid therapy in acute pancreatitis is critical for modulating the systemic inflammatory response. The choice between Lactated Ringer and normal saline remains debated, given their potentially divergent impacts on disease progression and clinically relevant outcomes. The objective of this meta-analysis is to determine the effectiveness of one solution versus the other in patients with AP.</p><p><strong>Methods: </strong>A systematic review of randomized clinical trials published between 2000 and 2024 was conducted through an exhaustive search in databases such as PubMed, ScienceDirect, LILACS, SCOPUS, Web of Science, Springer, Scielo, and Cochrane. The review protocol adhered to the recommendations established by PRISMA. The methodological quality of the selected studies was assessed using the Jadad scale, while statistical analyses were performed with RevMan 5.4<sup>®</sup> and Jamovi 2.3.28<sup>®</sup> software.</p><p><strong>Results: </strong>Five trials with 299 patients showed that, in patients with AP, Lactated Ringer significantly reduced ICU admission (RR: 0.39; 95% CI: 0.18-0.85; <i>p</i> = 0.02) and the progression of pancreatitis (RR: 0.63; 95% CI: 0.40-0.98; <i>p</i> = 0.04). There was no significant difference in mortality or hospital stay (SMD: -0.89; 95% CI: -2.26 to 0.48; <i>p</i> = 0.23). No clear effects were observed on SIRS at 24, 48, and 72 h. CRP at 48 h was significantly lower with lactate (SMD: -3.91; 95% CI: -4.66 to -3.17; <i>p</i> < 0.00001), but not at 72 h.</p><p><strong>Conclusions: </strong>The administration of Lactated Ringer in acute pancreatitis shows clinical and anti-inflammatory benefits, but the evidence is mostly of low quality.</p>\",\"PeriodicalId\":72832,\"journal\":{\"name\":\"Diseases (Basel, Switzerland)\",\"volume\":\"13 9\",\"pages\":\"\"},\"PeriodicalIF\":3.0000,\"publicationDate\":\"2025-09-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12468465/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Diseases (Basel, Switzerland)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3390/diseases13090300\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"MEDICINE, RESEARCH & EXPERIMENTAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diseases (Basel, Switzerland)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3390/diseases13090300","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0
摘要
背景:急性胰腺炎的初始液体治疗对于调节全身炎症反应至关重要。考虑到它们对疾病进展和临床相关结果的潜在不同影响,乳酸林格氏液和生理盐水之间的选择仍然存在争议。本荟萃分析的目的是确定一种解决方案相对于另一种解决方案在ap患者中的有效性。方法:通过在PubMed, ScienceDirect, LILACS, SCOPUS, Web of Science,施普林格,Scielo和Cochrane等数据库中进行详尽的搜索,对2000年至2024年间发表的随机临床试验进行系统回顾。审查议定书遵循PRISMA制定的建议。采用Jadad量表评价入选研究的方法学质量,采用RevMan 5.4®和Jamovi 2.3.28®软件进行统计分析。结果:299例AP患者的5项试验显示,乳酸林格可显著降低AP患者的ICU住院率(RR: 0.39; 95% CI: 0.18-0.85; p = 0.02)和胰腺炎的进展(RR: 0.63; 95% CI: 0.40-0.98; p = 0.04)。死亡率和住院时间无显著差异(SMD: -0.89; 95% CI: -2.26 ~ 0.48; p = 0.23)。在24、48和72 h时,对SIRS没有明显的影响。48 h时的CRP显著低于乳酸组(SMD: -3.91; 95% CI: -4.66至-3.17;p < 0.00001),但在72 h时则无明显差异。结论:急性胰腺炎给予乳酸林格格治疗具有临床和抗炎益处,但证据质量低。
Fluid Resuscitation with Lactated Ringer vs. Normal Saline in Acute Pancreatitis: A Systematic Review and Meta-Analysis of Clinical Trials.
Background: Initial fluid therapy in acute pancreatitis is critical for modulating the systemic inflammatory response. The choice between Lactated Ringer and normal saline remains debated, given their potentially divergent impacts on disease progression and clinically relevant outcomes. The objective of this meta-analysis is to determine the effectiveness of one solution versus the other in patients with AP.
Methods: A systematic review of randomized clinical trials published between 2000 and 2024 was conducted through an exhaustive search in databases such as PubMed, ScienceDirect, LILACS, SCOPUS, Web of Science, Springer, Scielo, and Cochrane. The review protocol adhered to the recommendations established by PRISMA. The methodological quality of the selected studies was assessed using the Jadad scale, while statistical analyses were performed with RevMan 5.4® and Jamovi 2.3.28® software.
Results: Five trials with 299 patients showed that, in patients with AP, Lactated Ringer significantly reduced ICU admission (RR: 0.39; 95% CI: 0.18-0.85; p = 0.02) and the progression of pancreatitis (RR: 0.63; 95% CI: 0.40-0.98; p = 0.04). There was no significant difference in mortality or hospital stay (SMD: -0.89; 95% CI: -2.26 to 0.48; p = 0.23). No clear effects were observed on SIRS at 24, 48, and 72 h. CRP at 48 h was significantly lower with lactate (SMD: -3.91; 95% CI: -4.66 to -3.17; p < 0.00001), but not at 72 h.
Conclusions: The administration of Lactated Ringer in acute pancreatitis shows clinical and anti-inflammatory benefits, but the evidence is mostly of low quality.